EFP, or Endometrial Function Profiling, is a diagnostic approach used in reproductive medicine to evaluate whether the lining of the uterus is developing properly and is ready to support embryo implantation. It analyzes specific protein markers in a small tissue sample from the uterine lining to identify problems that may be causing infertility or repeated pregnancy loss. The test is most commonly discussed in the context of IVF and other assisted reproductive treatments, where embryo quality is good but implantation still fails.
The abbreviation “EFP” also appears in other fields, including fisheries management (Exemption Fishing Permit) and military terminology (Explosively Formed Penetrator). This article covers the reproductive medicine meaning, which is the most common clinical use of the term.
What EFP Measures
The core idea behind Endometrial Function Profiling is that the uterine lining goes through a tightly regulated sequence of changes each menstrual cycle, and those changes need to happen on schedule for an embryo to implant successfully. EFP examines specific proteins involved in cell growth and development to determine whether the lining is progressing the way it should.
Two key markers are cyclin E and p27, both of which regulate how cells divide and mature. In a normally developing uterine lining, cyclin E shifts location within cells throughout the cycle. It moves from the base of the glandular cells during the middle of the proliferative phase to the cell nucleus around days 18 to 19, then disappears after day 20. The protein p27 first appears around days 17 to 19 and is found only in cell nuclei. In women experiencing infertility, cyclin E is more frequently detected after day 20, when it should already be gone. This lingering presence suggests the lining hasn’t matured on the expected timeline.
A related but distinct approach, endometrial immune profiling, looks at the immune environment of the uterine lining during the implantation window. This method measures the balance of immune signaling molecules and natural killer cells to detect immune dysregulation that could prevent an embryo from implanting. The immune profile is defined by the balance of specific signaling molecules and the presence of a type of immune cell identified by the marker CD56.
How the Test Works
EFP requires an endometrial biopsy, a brief in-office procedure where a thin catheter is inserted through the cervix to collect a small sample of uterine lining tissue. The procedure typically takes a few minutes and can cause cramping similar to menstrual cramps. Most women don’t need sedation, though some clinics offer it.
The tissue sample is then analyzed using immunohistochemistry, a laboratory technique that uses staining to reveal the presence, quantity, and location of specific proteins within cells. The results show whether the lining’s biochemical development matches where it should be on that day of the cycle. When hormone-stimulated cycles are involved, such as during IVF preparation, the staining patterns can differ from natural cycles. Research has shown that cyclin E staining in proliferative samples tends to be more intense in stimulated cycles compared to natural ones, while p27 staining stays the same.
For immune profiling specifically, recent evidence suggests that biopsy timing within the menstrual cycle may be less critical than previously thought. A study of women with recurrent pregnancy loss or repeated implantation failure found no significant difference in immune cell detection rates between biopsies taken during the proliferative phase versus the secretory phase.
Who Might Benefit From EFP
EFP is typically recommended for women who have experienced unexplained infertility, recurrent implantation failure during IVF, or recurrent pregnancy loss. The common thread in these situations is that standard evaluations, including embryo quality assessments, hormone levels, and imaging of the uterus, come back normal, yet pregnancy still doesn’t happen or doesn’t last.
The underlying hypothesis is straightforward: some implantation failures happen not because of the embryo but because of the uterine environment. The lining may look normal on an ultrasound but be biochemically out of sync or immunologically hostile to an embryo. EFP aims to catch these hidden problems so they can be addressed with targeted treatment before the next embryo transfer.
How EFP Differs From ERA
EFP and ERA (Endometrial Receptivity Analysis) are sometimes confused because both involve an endometrial biopsy and both aim to improve implantation outcomes. They work differently, though. ERA is a genetic test that analyzes the expression of roughly 238 genes to determine whether the lining is in its receptive window, essentially answering the question “is the timing right?” If the window is shifted, the embryo transfer can be adjusted by a day or two.
EFP takes a broader approach. Rather than focusing only on timing, it evaluates the biochemical and immune health of the lining itself. It can identify problems like delayed maturation (where the lining hasn’t progressed through its normal developmental stages) or immune imbalances that could interfere with implantation regardless of timing. In practice, some fertility specialists use both tests in combination for patients with repeated failures, using ERA to optimize transfer timing and EFP to identify and treat underlying lining dysfunction.
What Happens After the Results
When EFP identifies an abnormality, treatment is tailored to the specific finding. If the lining shows delayed development, with markers like cyclin E persisting past day 20, the issue may involve how the lining responds to progesterone. Adjustments to hormone support protocols can sometimes correct this. If immune profiling reveals an imbalance in natural killer cells or inflammatory signaling, treatments might include medications that modulate the immune response in the uterus.
The goal is personalized care rather than a one-size-fits-all protocol. By identifying the specific mechanism behind implantation failure, clinicians can move beyond the trial-and-error approach that characterizes much of fertility treatment. For women who have been through multiple failed IVF cycles without a clear explanation, this level of detail can provide both answers and a more targeted path forward.